Letermovir

Records for this ingredient, by country (identity only).

ATC J05AX18 · 12 markets · 44 records

Letermovir 12 markets · 44 records Forms
Filters
MarketUS 6CA 5AU 5HK 4JP 4FR 4SG 3TW 3GB 2ES 2MX 2EU 1

US 6 records · 5 shown of 5 Source openFDA NDC Directory · Data as of 2026-10-23

CA 5 records · 3 shown of 3 Source Health Canada Drug Product Databas · Data as of 2026-10-23

AU 5 records · 4 shown of 4 Source TGA、TGA CMI repository (consumer medic · Data as of 2026-10-28、live · some records have no stated strength · includes records with unknown status (not proof of sale)

  • 240 mgtabletPREVYMIS letermovir 240 mg film-coated tablet blister pack also in US·CA·JP
    +5Other 5 marketsFRSGTWGBES
     unknown
  • 480 mgtabletPREVYMIS letermovir 240 mg film-coated tablet blister pack also in US·CA·FR
    +3Other 3 marketsSGTWES
     unknown
  • 480 mg per mL / per unit basis not statedinjectionPREVYMIS letermovir 240 mg/12 mL concentrated injection for infusion vial unknown
  • 240 mg per mL / per unit basis not statedinjectionPREVYMIS letermovir 240 mg/12 mL concentrated injection for infusion vial unknown
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名PREVYMIS ×7

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

HK 4 records · 0 shown of 0 Source 衞生署藥物辦公室（香港）註冊藥劑製品名單 · Data as of 2026-10-23 · some records have no stated strength · includes records with unknown status (not proof of sale)

4 records · 0 manufacturers 4 registros · 0 fabricantes 4 个记录 · 0 个厂家 4 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名PREVYMIS ×14PREVYMIS CONCENTRATE FOR SOLUTION FOR INFUSION 240MG/12ML ×4

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

JP 4 records · 4 shown of 4 Source 厚生労働省 薬価基準収載品目リスト · Data as of 2026-11-01

FR 4 records · 4 shown of 4 Source Base de données publique des médic · Data as of 2026-11-03

SG 3 records · 3 shown of 3 Source Health Sciences Authority (HSA) · Data as of 2026-08-07

TW 3 records · 2 shown of 2 Source 衛生福利部食品藥物管理署（TFDA）全部藥品許可證資料集 · Data as of 2026-10-22 · some records have no stated strength

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名Prevymis Concentrate for Solution for Infusion 20mg/mL ×4滅巨斯輸注用濃縮溶液20毫克/毫升 ×2

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

GB 2 records · 2 shown of 2 Source NHSBSA dm+d · Data as of 2026-10-19

  • 240 mgtabletPREVYMIS also in US·CA·AU
    +5Other 5 marketsJPFRSGTWES
  • 240 mg/12 mLinjectionPrevymis 240mg/12ml concentrate for solution for infusion vials also in JP

ES 2 records · 2 shown of 2 Source CIMA (AEMPS) · Data as of live

MX 2 records · 0 shown of 0 Source COFEPRIS · Data as of annual · some records have no stated strength

2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名PREVYMIS ×14

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

EU 1 records · 0 shown of 0 Source European Commission · Data as of 2026-11-03 · some records have no stated strength

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名PREVYMIS ×7

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.